Polymyositis: Difference between revisions

Line 43: Line 43:
==Disposition==
==Disposition==
*Rheumatology or neurology consultation either in ED or as outpatient depending on severity of symptoms
*Rheumatology or neurology consultation either in ED or as outpatient depending on severity of symptoms
*Very strongly associated with malignancy (~30%), especially:<ref>Hill CL et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001 Jan 13;357(9250):96-100.</ref>
**Ovarian
**Lung
**Pancreatic
**Stomach
**Colorectal
**Lymphoma
**Bladder


==See Also==
==See Also==

Revision as of 08:32, 15 December 2022

Background

  • Idiopathic inflammatory myopathy causing symmetric proximal muscle weakness, elevated CK, and characteristic EMG findings

Clinical Features

  • Symmetrical proximal muscle weakness with insidious onset
  • Generally painless (though 30% have myalgia)
  • Difficulty with kneeling, climbing stairs, combing hair, or rising from a seated position
  • Weak neck extensors causing difficulty of holding head up
  • Associated arthralgias

Differential Diagnosis

Myalgia

Weakness

Evaluation

Workup

  • CBC
  • ESR
  • CRP
  • CK: Most sensitive muscle enzyme
  • Urinalysis
  • Consider:
    • LDH
    • AST/ALT
    • Aldolase
    • RF
    • ANA
    • Anti-Jo-1
    • Myositis antibody panel

Diagnosis

  • Typically requires muscle biopsy

Management

  • Prednisone 1mg/kg/day for 4-8 weeks until CK returns to reference range
  • Other treatments that rheum may prescribe:
    • Methotrexate as second line for poor response to corticosteroids
    • Other agents with less evidence: IVIG, TNF Inhibitors

Disposition

  • Rheumatology or neurology consultation either in ED or as outpatient depending on severity of symptoms

See Also

References